Overview
Masamitsu Takatama practices practicing medicine in Maebashi, Japan.
Takatama is highly rated in 9 conditions, according to our data. Their clinical expertise encompasses Monomelic Amyotrophy, Cerebral Amyloid Angiopathy, Siderosis, and Alzheimer's Disease.
They are actively involved in clinical research, co-authoring 42 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Masamitsu Takatama
Is Masamitsu Takatama a top-rated expert for Monomelic Amyotrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Masamitsu Takatama is classified as an Distinguished expert for Monomelic Amyotrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Masamitsu Takatama participate in research or clinical trials?
Yes. Masamitsu Takatama has published 42 articles and abstracts on conditions like Monomelic Amyotrophy. You can view a list of Masamitsu Takatama's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Monomelic AmyotrophyTakatama isDistinguished. Learn about Monomelic Amyotrophy.
- Advanced
- Alzheimer's DiseaseTakatama isAdvanced. Learn about Alzheimer's Disease.
- Cerebral Amyloid AngiopathyTakatama isAdvanced. Learn about Cerebral Amyloid Angiopathy.
- DementiaTakatama isAdvanced. Learn about Dementia.
- Familial Hypobetalipoproteinemia
- Primary AmyloidosisTakatama isAdvanced. Learn about Primary Amyloidosis.
- SiderosisTakatama isAdvanced. Learn about Siderosis.
- Spinal Muscular Atrophy Type 2
- Spinal Muscular Atrophy Type 3
- Experienced
- Acute Interstitial PneumoniaTakatama isExperienced. Learn about Acute Interstitial Pneumonia.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Developmental Dysphasia FamilialTakatama isExperienced. Learn about Developmental Dysphasia Familial.
- DysarthriaTakatama isExperienced. Learn about Dysarthria.
- Familial DysautonomiaTakatama isExperienced. Learn about Familial Dysautonomia.
- HypolipoproteinemiaTakatama isExperienced. Learn about Hypolipoproteinemia.
- Interstitial Lung DiseaseTakatama isExperienced. Learn about Interstitial Lung Disease.
- Movement DisordersTakatama isExperienced. Learn about Movement Disorders.
- Multiple System AtrophyTakatama isExperienced. Learn about Multiple System Atrophy.
- Muscle AtrophyTakatama isExperienced. Learn about Muscle Atrophy.
- Normal Pressure HydrocephalusTakatama isExperienced. Learn about Normal Pressure Hydrocephalus.
- PicaTakatama isExperienced. Learn about Pica.
- Primary Lateral SclerosisTakatama isExperienced. Learn about Primary Lateral Sclerosis.
- Primary Progressive AphasiaTakatama isExperienced. Learn about Primary Progressive Aphasia.
- Spinal Muscular Atrophy (SMA)Takatama isExperienced. Learn about Spinal Muscular Atrophy (SMA).